What is a GLP-1 energy drink?
An energy drink with an ingredient that raises your body’s own GLP-1, so the caffeine lift comes with a quieter appetite between meals. It is not a medication.
The short version
A GLP-1 energy drink does two jobs in one glass. The caffeine does what caffeine does. A second ingredient raises the amount of active GLP-1 your body produces, so the lift comes with a quieter appetite between meals.
It is not a medication. It does not contain semaglutide, tirzepatide or any other prescription compound. It works on the GLP-1 you already make.
Where the term comes from
GLP-1 became a household word because of prescription medications that mimic it. Once people understood what the hormone does, a category of foods and drinks followed, most of them built on protein or fiber, which trigger GLP-1 release after a meal.
A GLP-1 energy drink is a narrower idea. It takes the drink people already reach for in the morning or before training and adds an ingredient with human data on GLP-1 and body fat. Calla is built this way, with 300 mg of Micro GLP-1 in every stick.
What GLP-1 does
GLP-1 is a hormone made by cells in the lining of your gut. It is released when you eat. It tells your brain the meal is enough, slows how fast the stomach empties, and helps the pancreas respond to glucose. It is short-lived: an enzyme called DPP-4 breaks it down within minutes.
Two things set the level of active GLP-1 in your blood: how much is released, and how fast it is cleared. A drink can act on either.
How a drink raises it
There are two honest routes.
- Feed the signal. Protein and fermentable fiber prompt the gut to release more GLP-1. Any protein shake does some of this. The effect is real, modest and tied to the meal.
- Use an ingredient studied for it. Calla uses CQR-300, a standardized extract of the plant Cissus quadrangularis. In a 16-week randomized, placebo-controlled trial at 300 mg a day, active GLP-1 rose 321%, DPP-4 activity fell 17.8%, energy intake fell 17.5% and body fat fell 10.9%, all versus placebo.¹
The second route is what makes an energy drink a GLP-1 energy drink. Read the trial in full on the CQR-300 page.
What it is not
It is not a GLP-1 receptor agonist. Prescription medications are synthetic molecules that bind the GLP-1 receptor directly, resist breakdown for days, and produce effects far larger than any food or supplement. A GLP-1 energy drink nudges your own hormone. The scale is different and so are the rules: it is regulated as a food, not a drug, and it is not for treating any condition. The full comparison is here.
What to look for on a label
- A named, standardized ingredient, not a proprietary blend.
- A dose that matches the dose studied. For CQR-300 that is 300 mg a day.
- A human, placebo-controlled trial you can read.
- Caffeine stated in milligrams.
- Zero calories and zero sugar. A GLP-1 drink that costs you 100 calories is working against itself.
Where Calla fits
Calla is a daily energy drink. One stick, stirred into water: 150 mg caffeine, 200 mg L-theanine, 1 g taurine, vitamins B6 and B12, and 300 mg Micro GLP-1. Zero calories. Thirty sticks to a box, because the trial ran for weeks, not days.
¹ Medicina 62(1):41, 2026. Randomized, placebo-controlled, 16 weeks, 248 adults, 300 mg CQR-300 per day. A study of the ingredient, not of Calla. These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.